Some FDA-approved, in-office treatments use esketamine, a compound derived from ketamine, as part of clinical therapy for adults with depression.
Depression can reduce communication between different brain regions, which may contribute to persistent negative thoughts, difficulty concentrating, and low mood. These therapies work by targeting glutamate, a neurotransmitter that helps brain cells form new connections and support brain signaling.
All treatments are administered under the supervision of licensed healthcare providers in a clinical setting for adults with major depressive disorder who have not responded adequately to standard antidepressant therapies.
We review your mood, experiences, and any prior treatments to better understand your needs and guide your care.
Each patient is unique. Based on the consultation, a customized treatment plan is developed to address your specific situation.
All sessions are conducted in a clinical setting with medical supervision to ensure safety and proper monitoring.
Ongoing follow-ups allow healthcare providers to monitor progress and make adjustments to your care plan as needed.
Please fill out the form below so our licensed healthcare team can understand your needs and get in touch with you.
